RBM4 and breast carcinoma: Subsequently, we examined the effects of these two RBM4 isoforms on the proliferation of a variety of human cancer cells, including A549 and NCI-H460 (lung cancer), MDA-MB-231 (breast cancer), and HepG2 (liver cancer).